Glaukos develops and sells eye treatments, including glaucoma stents and drug implants, for ophthalmologists and other eye care professionals. It last closed at $237.31 on Nov 20, down 0.33% on the day. The next earnings report for GKOS is expected around Tue, Jan 12, 2027, after the close. For the quarter ended Sep 2026, GKOS reported EPS of $0.03 on revenue of $211.0M, with revenue up 58.0% from a year ago. Over its last 8 reports the stock moved an average of 14.1% the session after earnings. Over the last 12 months GKOS insiders bought $0 of stock on the open market and sold $136.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is GKOS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GKOS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GKOSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GKOS · as of the Nov 20 close · updated each morning
Uptrend
The stock is 3% above its 20 day and 20% above its 50 day average. It is 37% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 61). The nearest support is the Pivot S1 at $232.29, and the nearest resistance the Pivot at $238.42.
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 4.8%/day
Key levels
$255.1952 week high+7.5%
$250.61Swing high (Nov 16)+5.6%
$243.44Pivot R1+2.6%
$238.42Pivot+0.5%
$237.31Last close
$232.29Pivot S1−2.1%
$229.7120 day average−3.2%
$218.76Swing low (Nov 5)−7.8%
$190.9550 day average−19.5%
$180.19100 day average−24.1%
$150.33200 day average−36.7%
$93.7852 week low−60.5%
Indicators
RSI (14)
61.16
Strong, overbought above 70
Neutral
MACD
14.81
Below its signal line
Bearish
Stochastic
47.8
Middle of its range
Neutral
ADX (14)
41.4
Strong uptrend
Williams %R
-49.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
37.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+5.8%
Change over 10 sessions
Bullish
ATR (14)
$11.37
Typical daily range, 4.8% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 8.8%/day
Key levels
$255.1952 week high+7.5%
$250.61Swing high (Nov 16)+5.6%
$243.44Pivot R1+2.6%
$238.42Pivot+0.5%
$237.31Last close
$232.29Pivot S1−2.1%
$229.7120 day average−3.2%
$218.76Swing low (Nov 5)−7.8%
$190.9550 day average−19.5%
$180.19100 day average−24.1%
$150.33200 day average−36.7%
$93.7852 week low−60.5%
Indicators
RSI (14)
70.85
Overbought above 70
Overbought
MACD
23.91
Above its signal line
Bullish
Stochastic
82.2
Near the top of its range
Overbought
ADX (14)
35.3
Trending up
Williams %R
-16.4
Oversold below −80, overbought above −20
Overbought
CCI (20)
182.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+41.9%
Change over 10 sessions
Bullish
ATR (14)
$20.95
Typical daily range, 8.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for GKOS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GKOS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GKOS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GKOSHow many large options trades hit GKOS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GKOS in the last 90 days.
From SEC Form 4 filings by GKOS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GKOS is in one of them and how their past GKOS trades turned out.
Glaukos is an ophthalmic pharmaceutical and medical technology company based in Aliso Viejo, California. It makes procedural treatments for glaucoma, including small stents placed during eye surgery and a drug implant that releases medication inside the eye over time. It also sells treatments that strengthen the cornea for corneal disorders such as keratoconus, and it is developing therapies for retinal disease. Its customers are ophthalmologists and other eye care professionals.